Cite
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis.
MLA
Hufnagel, Demetra H., et al. “Expression of P52, a Non-Canonical NF-KappaB Transcription Factor, Is Associated with Poor Ovarian Cancer Prognosis.” Biomarker Research, vol. 8, Sept. 2020, p. 45. EBSCOhost, https://doi.org/10.1186/s40364-020-00227-y.
APA
Hufnagel, D. H., Wilson, A. J., Saxon, J., Blackwell, T. S., Watkins, J., Khabele, D., Crispens, M. A., Yull, F. E., & Beeghly-Fadiel, A. (2020). Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis. Biomarker Research, 8, 45. https://doi.org/10.1186/s40364-020-00227-y
Chicago
Hufnagel, Demetra H, Andrew J Wilson, Jamie Saxon, Timothy S Blackwell, Jaclyn Watkins, Dineo Khabele, Marta A Crispens, Fiona E Yull, and Alicia Beeghly-Fadiel. 2020. “Expression of P52, a Non-Canonical NF-KappaB Transcription Factor, Is Associated with Poor Ovarian Cancer Prognosis.” Biomarker Research 8 (September): 45. doi:10.1186/s40364-020-00227-y.